[1]黄颖 匡明杰 李云洁 赵僖格 钟馨桐 单敏慧 杨强 赵艳红.二甲双胍抑制骨细胞ROS产生及激活AKT信号通路改善糖皮质激素性骨质疏松[J].第三军医大学学报,2019,41(01):41-47.
 HUANG Ying,KUANG Mingjie,LI Yunjie,et al.Metfomin inhibits cellular reactive oxygen species and activates AKT signaling pathway to improve glucocorticoid-induced osteoporosis[J].J Third Mil Med Univ,2019,41(01):41-47.
点击复制

二甲双胍抑制骨细胞ROS产生及激活AKT信号通路改善糖皮质激素性骨质疏松(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第01期
页码:
41-47
栏目:
基础医学
出版日期:
2019-01-15

文章信息/Info

Title:
Metfomin inhibits cellular reactive oxygen species and activates AKT signaling pathway to improve glucocorticoid-induced osteoporosis
作者:
黄颖 匡明杰 李云洁 赵僖格 钟馨桐 单敏慧 杨强 赵艳红
天津医科大学口腔医学院正畸科 天津医科大学总医院骨科,天津大学天津医院脊柱一科
Author(s):
HUANG Ying KUANG Mingjie LI Yunjie ZHAO Xige ZHONG Xintong SHAN Minhui1 YANG Qiang ZHAO Yanhong

Department of Orthodontics, Stomatology Hospital of Tianjin Medical University, Tianjin, 300070; Department of Orthopedics, General Hospital of Tianjin Medical University, Tianjin, 300052; First Department of Spine, Tianjin Hospital of Tianjin University, Tianjin, 300211, China

关键词:
糖皮质激素诱发骨质疏松二甲双胍活性氧AKT信号通路
Keywords:
glucocorticoid-induced osteoporosis metformin reactive oxygen species AKT signaling pathway
分类号:
R681; R963; R977.15
文献标志码:
A
摘要:

目的   探究二甲双胍改善糖皮质激素诱发骨质疏松(glucocorticoid induced osteoporosis,GIOP)的作用机制。方法   分别用地塞米松(dexamethasone,DEX,10 μmol/L),DEX(10 μmol/L)+二甲双胍(1 mmol/L)处理MLO-Y4骨细胞,设置空白对照,分别用DCFH-DA探针测定骨细胞内ROS水平差异,Western blot检测AKT和Caspase-3蛋白表达差异,CCK-8实验检测细胞增殖活性,TUNEL染色评估细胞凋亡状态,RT-PCR检测SOD2和Cat相关mRNA表达。构建大鼠GIOP动物模型,通过micro-CT检测相关骨代谢参数值,评估二甲双胍对GIOP大鼠成骨作用的影响。结果   细胞增殖毒性实验显示DEX可降低骨细胞增殖活性,与空白对照组比较差异有统计学意义(P<0.05),DEX+二甲双胍组细胞增殖活性与空白对照组比较无明显差异。DCFH-DA探针免疫荧光染色显示,空白对照组和DEX+二甲双胍组细胞内ROS水平没有明显差异,而DEX组ROS水平明显高于其他两组,且RT-PCR显示SOD2和Cat mRNA的表达在DEX组中明显降低(P<0.05),表明酶抗氧化系统的缺陷。TUNEL染色显示DEX组细胞凋亡数量明显增加,而DEX+二甲双胍组和空白对照组无明显差异,且DEX组的Caspase3表达明显高于DEX+二甲双胍组和空白对照组,表明二甲双胍可以在DEX处理期间减少细胞凋亡数量。与DEX组相比,DEX+二甲双胍组中AKT蛋白高表达,说明二甲双胍可能激活AKT通路。与空白对照组相比,DEX组的显微结构参数值骨小梁厚度(TB.TH)、相对骨体积或骨体积分数(BV/TV)和骨小梁数量(TB.N)均显著降低(P<0.05),参数骨小梁分离度(Tb.Sp)显著升高(P<0.05),但DEX+二甲双胍组与空白对照组比较参数值无明显差异。结论   二甲双胍可降低糖皮质激素引起的细胞ROS水平升高,激活AKT信号通路,抑制蛋白水解酶Caspase-3的活性,调控骨细胞增殖凋亡并改善糖皮质激素诱发骨质疏松骨代谢。

Abstract:

Objective    To clarify the underlying mechanism of metformin in improvement of glucocorticoid induced osteoporosis (GIOP). Methods     Dexamethasone (DEX,10 μmol/L) alone or combined with metformin (1 mmol/L) was used to treat murine long bone osteocytes, Y4 (MLO-Y4), and the cells without any treatment served as blank control. Oxidant-sensing probe 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) was used to measure the production of reactive oxygen species (ROS), Western blotting was employed to detect the protein levels of AKT and Caspase-3, CCK-8 assay and TUNEL assay were conducted to study the cell viability and apoptosis, and realtime reverse transcriptase polymerase chain reaction (RT-PCR) was performed to test the mRNA levels of SOD2 and Cat. After the establishment of GIOP model in Sprague Dawley (SD) rats, micro-CT scanning was carried out to evaluate the effect of metformin on bone metabolism.  Results     CCK-8 assay demonstrated that DEX significantly reduced the proliferation of MLO-Y4 cells when compared with the blank control cells (P<0.05), while no obvious difference was seen between the DEX+metformin and control cells. DEX group had significantly higher ROS level than the DEX+metformin group and control group, but there was no difference between the latter 2 groups. RTPCR results showed that the mRNA levels of SOD2 and Cat were notably decreased in the DEX group (P<0.05), which indicating defects in enzymatic antioxidant defense system. TUNEL assay suggested the apoptosis was increased in the DEX group, but no difference was seen between the metformin group and control group. The results of Western blotting indicated that the DEX group had higher level of Caspase-3 than the other 2 groups, which suggested that metformin inhibits cell apoptosis induced by DEX, while, the AKT level was higher in the metformin group than the DEX group, showing that metformin activates the AKT signaling pathway. Compared with the blank control group, the microstructural parameters, including trabecular thickness (TB. TH), bone and tissue volume ratio (BV/TV), and trabecular number (TB. N) were obviously decreased (P<0.05), while trabecular spacing (TB.SP) was increased (P<0.05). But there were no significant differences in these parameters between the DEX+metformin group and control group.  Conclusion     Metformin reduces the increase of ROS levels induced by glucocorticoids, activates AKT signaling pathway, inhibits the activity of proteolytic enzyme Caspase-3, regulates proliferation and apoptosis of osteocytes, and thus improve bone metabolism of glucocorticoidinduced osteoporosis.

参考文献/References:

[1]SEIBEL M J, COOPER M S, ZHOU H.Glucocorticoidinduced osteoporosis:mechanisms,management, and future perspectives[J]. Lancet Diabetes Endocrinol, 2013, 1(1): 59-70. DOI:10.1016/S22138587(13)700457.
[2]VANSTAA T P, LEUFKENS H G, ABENHAIM L, et al. Oral corticosteroids and fracture risk:relationship to daily and cumulative doses[J].Rheumatol(Oxford), 2000, 39(12):1383-1389.DOI:10.1093/rheumatology/39.12.1383.
[3]白炜,冷晓梅.2017年美国风湿病学会糖皮质激素诱发的骨质疏松症预防及治疗指南概要解读[J].中华临床免疫和变态反应杂志,2017,11(4):313-317.DOI:10.3969/j.issn.16738705.2017.04.001.
BAI W,LENG X M. Reading 2017 ACR guideline for the prevention and treatment of GIOP[J]. Chin J Allergy Clin Immunol,2017,11(4):313-317.DOI:10.3969/j.issn.16738705.2017.04.001.
[4]PERNICOVA I, KORBONITS M. Metforminmode of action and clinical implications for diabetes and cancer[J]. Nat Rev Endocrinol,2014,10(3):143-156. DOI:10.1038/nrendo.2013.256.
[5]SHI J, WANG L, ZHANG H,et al.Glucocorticoids:Doserelated effects on osteoclast formation and function via reactive oxygen species and autophagy[J].Bone,2015,79:222-232.DOI:10.1016/j.bone.2015.06.014.
[6]KOUFALI M M, MOUTSATSOU P, SEKERIS C E, et al. The dynamic localization of the glucocorticoid receptor in rat C6 glioma cell mitochondria[J]. Mol Cell Endocrinol, 2003,209(1/2):51-60.DOI: 10.1016/j.mce.2003.07.003.
[7]母义明,纪立农,宁光,等.二甲双胍临床应用专家共识(2016年版)[J].中国糖尿病杂志,2016,24(10):871-884.DOI:10.3969/j.issn.10066187.2016.10.02.
MU Y M, JI L N, NING G, et al.Chinese experts consensus statement on Metformin in the clinical practice: 2016 updated[J]. Chin J Diabetes, 2016,24(10):871-884.DOI: 10.3969/j.issn.10066187.2016.10.02.
[8]RABINOVITCH R C, SAMBORSKA B, FAUBERT B, et al. AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species[J]. Cell Rep, 2017,21(1):1-9. DOI:10.1016/j.celrep.2017.09.026.
[9]MARYCZ K, TOMASZEWSKI K A, KORNICKA K, et al. Metformin decreases reactive oxygen species, enhances osteogenicproperties of adiposederived multipotent mesenchymal stem cells in vitro, and increases bone density in vivo[J]. Oxid Med Cell Longev, 2016,2016:1-19.DOI:10.1155/2016/9785890.
[10]李星霞,余奇,郭澄.二甲双胍的临床应用新进展[J].中国药房,2014,25(8):760-763.DOI: 10.6039/j.issn.10010408.2014.08.29.
LI X X,YU Q,GUO C.Recent progress in metformin clinical application[J]. China Pharmacy,2014,25(8):760-763. DOI: 10.6039/j.issn.1001-0408.2014.08.29.
[11]KANAZAWA I, YAMAGUCHI T, YANO S, et al. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3E1 cells via AMP kinase activation as well as eNOS and BMP2 expression[J]. Biochem Biophys Res Commun, 2008,375(3):414-419. DOI:10.1016/j.bbrc.2008.08.034.
[12]ALMEIDA M, O’BRIEN C A. Basic biology of skeletal aging: role of stress response pathways[J]. J Gerontol A BiolSci Med Sci,2013,68(10):1197-1208.DOI:10.1093/gerona/glt079.
[13]LUO G, XU B, HUANG Y. IcarisideⅡ promotes the osteogenic differentiation of canine bone marrow mesenchymal  stem cells via the PI3K/AKT/mTOR/S6K1 signaling pathways[J]. Am J Transl Res,2017,9(5):2077-2087.
[14]YING X, CHEN X, LIU H, et al. Silibinin alleviates high glucosesuppressed osteogenic differentiation of human bone marrow stromal cells via antioxidant effect and PI3K/Aktsignaling[J]. Eur J Pharmacol, 2015, 765:394-401.DOI:10.1016/j.ejphar.2015.09.005.
[15]LI H, LI T, FAN J, et al. miR216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cblmediated PI3K/AKT pathway[J].Cell Death Differ, 2015,22(12):1935-1945.DOI:10.1038/cdd.2015.99.
[16]LIU W, MAO L, JI F, et al. IcarisideⅡ activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone[J]. Oncotarget, 2017,8(2):2594-2603. DOI:10.18632/oncotarget.13732.
[17]HAN D, GAO J, GU X, et al. P21Waf1/Cip1depletion promotes dexamethasoneinduced apoptosis in osteoblastic MC3T3-E1 cells by inhibiting the Nrf2/HO1 pathway[J]. Arch Toxicol, 2018,92(2):679-692. DOI:10.1007/s00204-017-2070-2.

相似文献/References:

[1]卢薇,欧亚萍,梁英梅.二甲双胍对2型糖尿病患者血HS-CRP、TNF-α、ICAM-1水平的影响[J].第三军医大学学报,2008,30(18):1768.
[2]程莹,母义明,汪保安,等.二甲双胍减轻软脂酸诱导的血管内皮细胞损伤机制探讨[J].第三军医大学学报,2008,30(14):1357.
 CHENG Ying,MU Yi-ming,WANG Bao-an,et al.Protective mechanism of metformin in process of human umbilical vein endothelial cell injury induced by palmitic acid in vitro[J].J Third Mil Med Univ,2008,30(01):1357.
[3]李玉,彭颜晖.瑞格列奈联合二甲双胍治疗2型糖尿病疗效观察[J].第三军医大学学报,2009,31(18):1793.
[4]苏勇,王端,龙军,等.二甲双胍改善2型糖尿病合并舒张性心力衰竭患者心功能的临床研究[J].第三军医大学学报,2013,35(17):1862.
 Su Yong,Wang Duan,Long Jun,et al.Metformin improves heart function in patients having type 2 diabetes mellitus complicated with diastolic heart failure[J].J Third Mil Med Univ,2013,35(01):1862.
[5]石英,刘松青.复方盐酸二甲双胍片中格列本脲和二甲双胍溶出度的考察[J].第三军医大学学报,2005,27(11):1117.
[6]石英,刘松青,代青.LC-MS和HPLC法测定人血浆中格列本脲和二甲双胍方法的建立[J].第三军医大学学报,2005,27(08):731.
[7]章国亮,姜庆,江军.二甲双胍抑制IL-6诱导的LNCaP增殖及上皮-间质转化[J].第三军医大学学报,2013,35(13):1337.
 Zhang Guoliang,Jiang Qing,Jiang Jun.Metformin inhibits IL-6-induced LNCaP proliferation and epithelial-mesenchymal transition[J].J Third Mil Med Univ,2013,35(01):1337.
[8]张先祥,阳皓,杨刚毅,等.艾塞那肽与沙格列汀联合二甲双胍治疗2型糖尿病患者的疗效与安全性比较[J].第三军医大学学报,2013,35(14):1531.
 Zhang Xianxiang,Yang Hao,Yang Gangyi,et al.Efficacy and safety of exenatide versus saxagliptin combined with metformin in patients with type 2 diabetes mellitus[J].J Third Mil Med Univ,2013,35(01):1531.
[9]廖涌,黄健,孟平,等.胰岛素加二甲双胍治疗2型糖尿病疗效观察[J].第三军医大学学报,2003,25(11):0.[doi:10.16016/j.1000-5404.2003.11.027 ]

更新日期/Last Update: 2019-01-14